Clinical Trials Browser

TVB-2640 × Tumor-Agnostic × Clear all

NCT02223247 2017-08-14

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

Phase 1 Completed

Neoplasms